Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

520
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
520
Glaucoma: Overview01:25

Glaucoma: Overview

685
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
685
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

613
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
613

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safe use of fluorinated gases in vitreoretinal surgery: learning from patient safety incidents with expert panel recommendations from the British and Eire Association of Vitreoretinal Surgeons (BEAVRS).

The British journal of ophthalmology·2026
Same author

Ocular and Orbital Involvement in Extranodal Natural Killer/T-cell Lymphoma: A Systematic Review of Clinical Outcomes and Prognostic Factors.

Cureus·2026
Same author

Ocular Lymphatics in Health and Disease.

Diagnostics (Basel, Switzerland)·2026
Same author

Anatomic and Functional Outcomes after Pars Plana Vitrectomy for Giant Retinal Tear-Related Retinal Detachment: The Manchester Giant Retinal Tear Study.

Ophthalmology. Retina·2026
Same author

To Drain or Not to Drain? The Manchester Buckle Study.

Retina (Philadelphia, Pa.)·2026
Same author

Response to letter to the editor: macular volume in macular pucker.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie·2026

Related Experiment Video

Updated: Aug 19, 2025

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

1.5K

Neovascular Glaucoma: An Update.

Dimitrios Kalogeropoulos1, George Moussa2, Velota Ct Sung2

  • 1Ophthalmology, University General Hospital of Ioannina, Ioannina, Greece.

Klinische Monatsblatter Fur Augenheilkunde
|November 27, 2022
PubMed
Summary
This summary is machine-generated.

Neovascular glaucoma (NVG) is a severe eye condition causing high intraocular pressure due to abnormal blood vessel growth. Early diagnosis and treatment targeting retinal ischemia are crucial for managing NVG and preserving vision.

More Related Videos

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
08:30

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

13.2K
Experimental Glaucoma Induced by Ocular Injection of Magnetic Microspheres
06:35

Experimental Glaucoma Induced by Ocular Injection of Magnetic Microspheres

Published on: February 2, 2015

17.3K

Related Experiment Videos

Last Updated: Aug 19, 2025

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

1.5K
Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
08:30

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

13.2K
Experimental Glaucoma Induced by Ocular Injection of Magnetic Microspheres
06:35

Experimental Glaucoma Induced by Ocular Injection of Magnetic Microspheres

Published on: February 2, 2015

17.3K

Area of Science:

  • Ophthalmology
  • Glaucoma Research
  • Vascular Biology

Background:

  • Neovascular glaucoma (NVG) is a severe secondary glaucoma characterized by neovascularization of the iris and iridocorneal angle.
  • It leads to elevated intraocular pressure (IOP) due to blocked aqueous humor outflow, often resulting in poor visual prognosis.
  • NVG is frequently linked to posterior segment ischemia, commonly caused by proliferative diabetic retinopathy or central retinal vein occlusion.

Purpose of the Study:

  • To review current knowledge on the pathogenesis of neovascular glaucoma.
  • To discuss the management strategies for neovascular glaucoma.
  • To highlight the importance of early diagnosis and etiology identification for improved outcomes.

Main Methods:

  • Literature review of existing studies on NVG pathogenesis and treatment.
  • Analysis of therapeutic approaches including panretinal photocoagulation, anti-VEGF therapy, medical management, and surgical interventions.
  • Emphasis on diagnostic criteria and etiological factors.

Main Results:

  • NVG is characterized by iris and angle neovascularization, leading to extremely high IOP, ocular pain, and vision loss.
  • Treatment involves addressing retinal ischemia (panretinal photocoagulation), promoting neovascularization regression (anti-VEGF), and controlling IOP (medications, surgery).
  • Prompt diagnosis and identification of underlying causes are vital for effective management and visual preservation.

Conclusions:

  • Effective management of NVG requires a multi-faceted approach addressing both the neovascularization and the elevated IOP.
  • Early intervention and targeted therapies can significantly improve visual outcomes in patients with NVG.
  • Further research into the pathogenesis and novel therapeutic strategies for NVG is warranted.